These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6121848)

  • 1. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
    J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
    Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes in the chronotropic effect and the enzymic decarboxylation of L-threo-3,4-dihydroxphenylserine in the rat heart.
    Araki H; Fujiwara H; Tanaka C
    J Pharm Pharmacol; 1981 Dec; 33(12):778-82. PubMed ID: 6121849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
    Satoh S; Oyabe A; Tanno M; Suzuki-Kusaba M
    Arzneimittelforschung; 1989 Sep; 39(9):1123-9. PubMed ID: 2511849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats.
    Ishikawa Y; Kato Y; Murakami Y; Inoue T; Koshiyama H; Imura H
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):197-200. PubMed ID: 3101067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy.
    Suzuki T; Higa S; Tsuge I; Sakoda S; Hayashi A; Yamamura Y; Takaba Y; Nakajima A
    Eur J Clin Pharmacol; 1980 Jun; 17(6):429-35. PubMed ID: 6772451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-threo-dihydroxyphenylserine on spinal reflexes and decerebrate rigidity in rats.
    Ono H; Tanabe M; Nakamura T; Nagano N; Fukuda H
    Gen Pharmacol; 1988; 19(3):369-72. PubMed ID: 3138156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
    Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
    Sato E; Irie T; Katsube J
    Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic effect of L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, in rats and mice.
    Katsube J; Kato T; Katsuyama M; Maeda Y; Nishikawa S; Nakamura M
    J Pharm Pharmacol; 1986 Jul; 38(7):533-4. PubMed ID: 2875157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
    Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
    Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The noradrenaline precursor L-threo-3,4-dihydroxyphenylserine exhibits antinociceptive activity via central alpha-adrenoceptors in the mouse.
    Kawabata A; Kasamatsu K; Umeda N; Takagi H
    Br J Pharmacol; 1994 Feb; 111(2):503-8. PubMed ID: 7911717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-threo- and erythro-3,4-dihydroxyphenylserine on learning performance and concentrations of brain noradrenaline and its metabolites in rats.
    Harada H; Noto T; Tsuji M; Taga C; Hashimoto H; Nakajima T
    Pharmacol Biochem Behav; 1992 Sep; 43(1):215-21. PubMed ID: 1409807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
    Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
    Ohmura I; Inagaki C; Araki H; Tanaka C
    Jpn J Pharmacol; 1978 Oct; 28(5):747-53. PubMed ID: 31501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressor action of L-threo-dihydroxyphenylserine in the rat nucleus tractus solitarii.
    Miyamae T; Yue JL; Goshima Y; Misu Y
    Eur J Pharmacol; 1996 Apr; 300(1-2):105-8. PubMed ID: 8741173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
    Hoeldtke RD; Cilmi KM; Mattis-Graves K
    Clin Pharmacol Ther; 1984 Sep; 36(3):302-6. PubMed ID: 6432398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.
    Suzuki T; Higa S; Sakoda S; Ueji M; Hayashi A; Takaba Y; Nakajima A
    Eur J Clin Pharmacol; 1982; 23(5):463-8. PubMed ID: 6818040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
    Lamotte G; Holmes C; Sullivan P; Goldstein DS
    Clin Auton Res; 2019 Feb; 29(1):113-117. PubMed ID: 30229336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.